Tag:

proteomics

Latest Headlines

Latest Headlines

Illumina teams with AB Sciex to add proteomics apps to BaseSpace

Illumina has teamed up with AB Sciex to add proteomic data analysis capabilities to its BaseSpace platform. As a result of the collaboration, Illumina is hosting four apps for processing, analyzing and visualizing proteomics mass spectrometry data on BaseSpace.

GSK teams up to apply Big Data to target validation

The combination of genomics and bioinformatics expertise now needed for target validation has led drugmakers to look outside their walls for skills, with Pfizer teaming with the Broad Institute on such a project. Now GlaxoSmithKline has set up its own initiative and called for its Big Pharma peers to get involved.

Applied Proteomics bags $28M round to roll out colon cancer test

San Diego's Advanced Proteomics is gearing up to launch its first diagnostic tests, and now the company has $28 million to get it there thanks to a just-closed Series C.

Chlamydia vaccine protects in animal studies

The vaccine developer Genocea Biosciences has used its in-house proteomics screening technology, AnTigen Lead Acquisition System (ATLAS), to identify two potential candidates for C trachomatis vaccines.

GSK snags proteomics platform tech in $98M Cellzome buyout

GSK has opted to buy out the company for $98 million, snagging full rights to a pair of early-stage inflammation programs and a proteomics technology.

Integrated's $10M to fuel diagnostics clinical work

Startup Integrated Diagnostics has reeled in another $10 million to fuel further clinical work on its in vitro proteomic-based diagnostics programs, with an eye toward hitting the commercial market...

Proteomics companies create new network

A group of 13 proteomics service companies and providers have banded together to create the Proteomics Innovation Network. Its stated mission is to generate "from sample to discovery" solutions in

Exomes and proteomics get funding

Federal funding is furthering research in two areas: DNA sequencing and proteomics. First, The National Heart, Lung, and Blood Institute has allocated $64 million in American Recovery and